http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2281133-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06069
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
filingDate 1975-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2281133-A1
titleOfInvention PEPTIDE CYCLOPROPYLAMIDES, THEIR PREPARATION AND THEIR APPLICATIONS
abstract Peptides of formula (I): (where Tyr may be replaced by the Phe and Leu7 may be replaced by Ser(But), Asp(OBnt), Glu(OBut), Lys(Boc) or Orn(Boc)), are used in the treatment of male and female sterility of hypothalamic or hypophysaric origin. They are also useful in determining the moment of ovulation. (I) have greater activity than similar known peptides, and may be administered orally or intranasally as well as parenterally.
priorityDate 1974-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416153991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410531710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21450380

Total number of triples: 20.